Skip to Content Skip to Footer
Yun Lyna Luo, PhD

Yun Lyna Luo, PhD

Associate Professor

College of Pharmacy

luoy@westernu.edu

Phone: (909) 469-8377 | Fax: (909) 469-5600

Website: https://sites.google.com/site/lynayunluo/

Join year: 2013 Aug

  • Education
    • Postdoc, Argonne National Laboratory, US 2011-2013
    • Postdoc, University of Chicago, US 2008-2011
    • Ph.D. Ecole Normale Supérieure, University of Paris VI, France 2004-2007
    • BS. MS. Zhejiang University, China 1997-2004
  • Courses

    · Molecular Simulation and Drug Design, 3 Credit Hours

    · Pharmacological Basis of Therapeutics I-IV (Medicinal Chemistry topics), 48 Lecture hours/year

    · Advanced Pharmaceutical Sciences II (Drug Metabolism, Acid-base Chemistry, Drug Design topics), 12 Lecture hours/year

    · Graduate Seminar, 2 Credit Hours, Facilitator

    · Interprofessional Practice & Education, Facilitator

  • Research Interest

    As a computational chemistry/biophysics research group, we investigate the structural dynamics of complex biomolecules and conduct mechanism-based drug design.

    The ongoing projects are:

    Mechanical and chemical gating of mechanosensitive Piezo channels;

    Gating and molecular permeation of connexin hemichannels;

    Gating mechanism of HCN channels;

    Computational method for reversible covalent drug design;

    Computational method for protein allosteric network analysis;

  • Research Grant

    NIH R01 GM130834 (PI) 09/05/2019-05/31/2023

    Title: Mechanism of mechanical and chemical gating in mechanosensitive Piezo1 channels

    NIH R01 GM099490(co-I) 08/15/2022-06/30/2025

    Title: Gating and regulation of Connexin hemihannels

    NIH R01 GM139164 (co-I) 05/01/2021-05/31/2024

    Title: Activation Mechanism in HCN Channels

    U.S. Deparment of Defense BA170606 (co-I) 07/01/2019-06/30/2023

    Title: Optimization of a selective calpain-2 inhibitor for prolonged field care in traumatic brain injury

    NSF XSEDE research allocationMCB160119(PI) 01/01/2018-06/31/2022

    Title: Computational Study of Small Molecule Recognition and Permeation

    Pittsburgh Supercomputing Center Anton Allocation Award (PI) 12/07/2017-11/30/2022

    Title: Chemical Activation of the Mechanosensitive Piezo1 Channel with Yoda1


    WesternU Intramural Research Grant (PI) 07/01/2018-07/01/2019

    Title: Pharmacology and gating mechanism of Piezo channels

    NIH R21 NS090397-01A1 (PI) 07/01/2015-06/30/2018

    Title: Development of a selective calpain-2 inhibitor for treating learning impairment in AS

  • Organizations

    Member of

    Biophysical Society (BPS)

    BPS Membrane Transport Subgroup (elected Secretary-Treasure 2022)

    American Chemical Society (ACS)

    American Association for the Advancement of Science (AAAS)

    American Association of Colleges of Pharmacy (AACP)

    Chinese American Faculty Association (CAFA) Southern California (electedPresident 2020)

    Meeting Organizer of

    Membrane Protein Simulations and Free Energy Approaches, ACS, Boston, August 19-23, 2018

    Beyond Kd: New Computational Methods to Address Challenges in Drug Discovery,CECAM Workshop, Lausanne, Switzerland, June 6-9, 2017

    Editorial Board Member of Communications Biology

    Editor of Journal of Computational Chemistry, "Membrane Protein Simulations and Free Energy Approaches" Special Issue 2020

    Journal Reviewer of

    Nature Communications, Science Advances, eLife; Journal of the American Chemical Society; Journal of Chemical Theory and Computation; Communication Biology; Biophysical Journal; Journal of Chemical Information and Modeling; The Journal of Physical Chemistry B.; The Journal of Chemical Physics, Journal of Computational Chemistry; PROTEINS: Structure, Function, and Bioinformatics; BBA – Biomembrane;, Scientific Reports; Current Opinion in Structural Biology; European Journal of Medicinal Chemistry; Bioorganic & Medicinal Chemistry Letters; ACS Omega; International Journal of Molecular Science;, Journal of Molecular Graphics and Modeling; PeerJ; Molecules; Computational Biology and Chemistry; PLOS One; Frontiers Oncology, PeerJ; Molecules; Computational Biology and Chemistry; Journal of Biomolecular Structure & Dynamics

    Grant Proposal Reviewer of

    ACS Petroleum Research Fund; Centre Européen de Calcul Atomique et Moléculaire (CECAM) Workshop Proposals; AACP New Investigator Award Grants; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants

  • Committees

    College Reward and Recognition Committee (chair)

    College Student Performance Committee (chair)

    College Tenure and Promotion Committee

    Vice chair of Department of Pharmaceutical Sciences

    University Awards Committee

    College Curriculum Committee

    College Faculty Secretary

    College Peer Evaluation Committee

    Master of Science in Pharmaceutical Sciences (MSPS) Admission Committee

    MSPS Graduate Program Committee

    MSPS Self-Study Committee

  • Publications

    Work from WesternU (since 2015, corresponding author *)

    2021

    1. Luo Y, Mechanism-Based and Computational-Driven Covalent Drug Design, J. Chem. Inf. Model. 2021, 61,5307-5311. (Viewpoint)

    2. Jiang, W., Lacroix, J*, Luo, Y.*, Lipids in the Piezo1 channel pore: gating mechanism, or simulation artifact? doi.org/10.1101/2021.11.28.470286

    3. Lin, Y., Luo, Y.*, Unifying Single-channel permeability from rare-event sampling and steady-state flux,Frontiers in Molecular Biosciences: Biological Modeling and Simulation, 2022.

    4. Jiang, W., Del Rosario, J.S., Botello-Smith, W., Zhao, S., Lin, Y., Zhang, Han., Lacroix, J.*, Rohacs, T.*, Luo, Y.*, Crowding-induced opening of the mechanosensitive Piezo1 channel in silico. Commun. Biol. 4, 84, 2021

    5. Jiang, W., Ling, Y., Luo, Y.*, Mechanical properties of anionic asymmetric bilayers from atomistic simulations, J. Chem. Phys., 2021

    6. Jiang, W., Lin, Y., Botello-Smith, W., Contreras, J.*, Harris, A.*, Maragliano, L.*, Luo, Y.*, Free energy and kinetics of cAMP permeation through connexin26 hemichannel via applied voltage and milestoning, Biophys. J., 2021

    7. Sterling, J.*, Jiang, W., Botello-Smith, W., Luo, Y.*, Ion pairing and dielectric decrement in glycosaminoglycan brushes, J. Phys. Chem. B., 2021

    8. Botello-Smith, W., Luo, Y., Concepts, practices, and interactive tutorial for allosteric network analysis of molecular dynamics simulations. Methods Mol. Biol. 2021, 2302, 311

    9. Luo, Y., Lacroix, J., Methods & challenges to study mechanosensitive ion channels. In L. Zhou, editor, Ion channels in biophysics and physiology. Springer.

    2020

    10. Botello-Smith, W, Luo, Y.*, Investigating protein-protein allosteric network using current-flow scheme, J. Comput. Chem, 2020, 41, 552-560

    11. Im, W., Banavali, N., Luo, Y., Celebrating benoit Roux’s 60th birthday: quantifying biology at the membrane. J. Comput. Chem, 2020 (Editorial)

    12. Gaete PS, Lillo MA, López W, Liu Y, Jiang W, Luo Y, Harris AL, Contreras JE., A novel voltage-clamp/dye uptake assay reveals saturable transport of molecules through CALHM1 and connexin channels, J Gen Physiol. 2020 Nov 2;152(11):e202012607.

    13. Anderson, S., Tabassum, A., Yeon, J., Sharma, G., Santos, P., Soong, T., Thu, Y., Nies, I., Kurita, T., Chandler, A., Alsamarah, A., Kanassatega, R., Luo, Y.*, Botello-Smith, W.*, Andresen, B.*, In silico prediction of ARB resistance: A first step in creating personalized ARB therapy. PLOS Comput. Biol., 2020.

    14. Xie, C.; Jiang, W.; Lacroix, J.J.;Luo, Y.*; Hao, J*. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.Int. J. Mol. Sci.2020,21, 6498.

    15. Sun J, Liu Y, Zhu G, Cato C, Hao X, Qian L, Lin W, Adhikari R,Luo Y, Baudry M, Bi X., PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome,Sci. Rep.2020, 10, 9824.

    2019

    16. Botello-Smith W, Zhang H, Ozkan AD, Jiang W, Pham CN, Lacroix J* and Luo Y*, A molecular Mechanism for the Chemical Activation of the Mechanosensitive Piezo1 Channel, Nat. Commun., DOI: 10.1038/s41467-019-12501-1.

    17. Zhu Y, He X, Lin YC, Dong H, Zhang L, Chen X, Wang Z, Shen Y, Li M, Wang H, Sun J, Nguyen LX, Zhang H, Jiang W, Yang Y, Chen J, Müschen M, Chen CW, Konopleva MY, Sun W, Jin J, Carlesso N, Marcucci G, Luo Y, Li L., Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia, Blood, DOI: 10.1182/blood.2019002457.

    18. Botello-Smith, W., Luo, Y.*, Robust determination of protein allosteric signaling pathways, J. Chem. Theory Comput., 2019, 15, 2116-2126.

    19. Capuccino, J., Chatterjee, P., Garcia, I., Botello-Smith, W., Zhang, H., Harris, A., Luo, Y.*, Contreras, J.*, The connexin26 human mutation N14K disrupts cytosolic intersubunit interactions and promotes channel opening, J. Gen. Physiol., 2019, 151, 382-341.

    20. Zhang, H., Jiang, W., Chatterjee P., Luo, Y.*, Ranking reversible covalent drugs: from free energy perturbation to fragment docking, J. Chem. Inf. Model, 2019, 59, 2093-2102.

    21. He X, Zhu Y, Lin YC, Li M, Du J, Dong H, Sun J, Zhu L, Wang H, Ding Z, Zhang L, Zhang L, Zhao D, Wang Z, Wu H, Zhang H, Jiang W, Xu Y, Jin J, Shen Y, Perry J, Zhao X, Zhang B, Liu S, Xue SL, Shen B, Chen CW, Chen J, Khaled S, Kuo YH, Marcucci G, Luo Y, Li L., PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia, Blood, 2019, 134, 548-560.

    2018

    22. Lacroix, J.*, Botello-Smith, W., Luo, Y., Probing the gating mechanism of the mechanosensitive channel Piezo1 with the small molecule Yoda1, Nat. Commun., 2018, 9, 2029.

    23. Q. Fei, D. Kent, W. Botello-Smith, F. Nur, S. Nur, A. Alsamarah, P. Chatterjee, M. Lambros*, Y. Luo*, Molecular mechanism of resveratrol’s lipid membrane protection, Sci. Rep., 2018, 8, 1587.

    24. Abrams CK, Peinado A, Mahmoud R, Bocarsly M, Zhang H, Chang P, Botello-Smith WM, Freidin MM, Luo Y., Alterations at Arg76 of human connexin 46, a residue associated with cataract formation, cause loss of gap junction formation but preserve hemichannel function. Am. J. Physiol. Cell Physiol.2018, 315, 623-635.

    25. Chatterjee, P., Yadav, M., Chauhan, N., Huang, Y., Luo, Y., Cancer cell metabolism featuring Nrf2. Curr. Drug Discov. Technol. 2018, doi: 10.2174/1570163815666180911092443.

    26. M. Liu, K. Huang, L. Qian, P. Chatterjee, S. Zhang, R. Li, S. Zhou, Z. Wang, Y. Luo, Y. Huang, Effects of bioactive constituents in the Traditional Chinese Medicinal formula Si-Wu-Tang on Nrf2 signaling and neoplastic cellular transformation, Phytomedicine, 2018, 40, 1-9.

    2017

    27. P. Chatterjee,W. Botello-Smith,H. Zhang,L Qian,A. Alsamarah,D. Kent,J. Lacroix,M. Baudry,Y. Luo*,Can relative binding free energy predict selectivity of reversible covalent inhibitors?J. Am. Chem. Soc.2017, 139, 17945-17952.

    28. W. Botello-Smith, A. Alsamarah, P. Chatterjee, C. Xie, J.J. Lacroix, J.Hao*, Y. Luo*, Polymodal allosteric regulation of type 1 serine/threonine kinase receptors via a conserved electrostatic lock, PLOS Comput. Biol.,2017, 13, e1005711.

    2016

    29. Y. Luo*, A. R. Rossi, A. L. Harris, Computational Studies of Molecular Permeation through Connexin26 Channels, Biophys. J., 2016, 110, 584-599.

    30. W. Lopez, J. Ramachandran, A. Alsamarah, Y. Luo, A. L. Harris, and J. E. Contreras, Mechanism of gating by calcium in connexin hemichannels, Proc. Natl. Acad. Sci. U S A,2016, 113, E7986-E7995.

    31. Y. Luo*, A. Alsamarah, K. Zhang, J. Hao*. Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva. Curr Mol Med., 2016, 16, 4-11.

    2015

    32. A. Alsamarah, AE, LaCuran, P. Oelschlaeger, J. Hao, Y. Luo*, Uncovering molecular bases underlying bone morphogenetic protein receptor inhibitor selectivity. PLOS ONE, 2015, 10, e0132221.

    33. J. Sun, G. Zhu, Y. Liu, S. Standley, A. Ji, R. Tunuguntla, Y. Wang, C. Claus, Y. Luo, M. Baudry, X. Bi, UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis. Cell Rep., 2015, 12, 359-360.

    34. Y. Luo*, J. Lacroix, S. Prabhu. Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer, Section V Case Studies, Chapter 12: Ado-Trastuzumab Emtansine, Springer, 2015.

    Patent

    35. M. Baudry, Y. Luo, N. Peet, Calpain-2 selective inhibitors, Full Patent Application; No. PCT/US2015/06015.

    Work Before WesternU

    36. W. Jiang, J. C. Phillips, L. Huang, M. Fajer, Y. Meng, J. C. Gumbart, Y. Luo, K. Schulten, B. Roux, Generalized scalable multiple copy algorithms for molecular dynamics simulations in NAMD. Comput. Phys. Commun., 2014, 185 (3), 908-916.

    37. R. M. Venable, Y. Luo, K. Gawrisch, B. Roux, R. W. Pastor, Simulations of Anionic Lipid Membranes: Development of Interaction-Specific Ion Parameters and Validation Using NMR Data. J. Phys. Chem. B. 2013 117 (35), 10183-10192.

    38. P. E. M. Lopes, J. Huang, J. Shim, Y. Luo, H. Li, B. Roux and A. D. MacKerell, Jr., Polarizable Force field for peptides and protein based the Classical Drude Oscillator. J. Chem. Theory Comput., 2013 9 (12), 5430-5449.

    39. Y. Luo, W. Jiang, H. Yu, A. D. MacKerell, Jr., and B. Roux, Calibrating the potential function for accurate ion pairing in molecular dynamics simulations of concentration electrolytes solutions. Faraday Discussions, 2013, 160, 135-149.

    40. W. Jiang, Y. Luo (co-1st), L. Maragliano, B. Roux, Calculation of Free Energy Landscape in Multi-Dimensions with Hamiltonian-Exchange Umbrella Sampling on Petascale Supercomputer. J. Chem. Theory Comput., 2012, 8 (11), 4672-4680.

    41. Y. Luo, E. Harder, R. S. Faibish and B. Roux, Computer simulations of water flux and salt permeability of the reverse osmosis FT-30 aromatic polyamide membrane. J. Mem. Sci. 2011, 384 (1-2), 1-9.

    42. J. Herrou, G. Rotskoff, Y. Luo, B. Roux and S. Crosson, The structural basis of a protein partner switch that regulates stress-dependent transcription. Proc. Natl. Acad. Sci. U S A, 2012, 109 (21): E1415-23.

    43. Y. Luo and B. Roux, Simulation of osmotic pressure in concentrated aqueous salt solutions. J. Phys. Chem. Lett. 2010, 1 (1), 183–189

    44. Y. Luo, B. Egwolf, D. E. Walters, and B. Roux, Ion selectivity of alpha-hemolysin with beta-cyclodextrin adapter: I. Single ion potential of mean force calculations and diffusion coefficient. J. Phys. Chem. B, 2010, 114 (2), 952–958

    45. B. Egwolf, Y. Luo, D. E. Walters, and B, Roux, Ion selectivity of alpha-hemolysin with beta-cyclodextrin adapter:II. Multi ion effects studies with grand canonical monte carlo/brownian dynamics simulations. J. Phys. Chem. B, 2010, 114 (8), 2901–2909

    46. Y. Luo, F. Barbault, C. Gourmala, Y. M. Zhang, F. Maurel, Y. Z. Hu and B. T. Fan, Cellular interaction through LewisX cluster: theoretical studies.J. Mol. Model, 2008, 14, 901-910.

    47. C. Gourmala, Y. Luo, F. Barbault, Y. M. Zhang, S. Ghalem, F. Maurel and B. T. Fan, Elucidation of the LewisX-LewisX carbohydrate interaction with molecular dynamics simulations. J. Mol. Struct.: THEOCHEM, 2007, 821, 22-29.

    48. F. Barbault, J. Rebehmed, C. Teixeira, Y. Luo, O. Smila-Castro, F. Maurel, B. T. Fan, Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site. Eur. J. Med. Chem. 2008, 43, 1648-56.

    49. Y. Luo, C. Gourmala, D. Dong, F. Barbault, B. T. Fan, Y. Z. Hu, Y. M. Zhang*, First synthesis of two deoxy Lewisx pentaosyl glycosphingolipids. Glycoconjugate J., 2008, 25, 335-344.

    50. Y. Luo, D. X. Dong, F. Barbault, B. T. Fan, Y. Z. Hu, Y. M. Zhang, Total synthesis of 4d-deoxy Lewisx pentasaccharide. Comptes Rendus Chimie, 2008, 11, 29-37.

    51. Y. Luo, Y. Z. Hu, Synthesis and Antifungal Activity of 2-Aryl-1,2,4-triazolo[1,5-a]pyridine Derivatives. Archiv der Pharmazie, 2006, 339, 262-266.

    52. Gourmala C.; Zhu Z. Y.; Luo Y.; Fan B. T.; Ghalem S.; Hu Y. Z.; Zhang Y. M. First synthesis of 3’-deoxy Lewisx pentasaccharide. Tetrahedron: Asymmetry 2005, 16, 3024-3029.

    53. Y. Luo, Y. Z. Hu, Synthesis of 1- (2′-bromo-2′-deoxy-3′,5′-di-O-propionyl-β-D-ribosyl) thymidine. Chin. J. Modern Applied Pharmacy 2004, 21,197-198.

    54. Y. Luo, Y. Z. Hu, A Novel and Efficient Strategy for the Preparation of 2,4-disubstituted -1,2,3-triazoles. Synth. Commun., 2003, 33, 3513-3517.

    55. Y. Luo, Y. Z. Hu, Cyclin-dependent kinase inhibitor: Novel approaches for cancer therapy. Chin. J. Modern Applied Pharmacy 2003, 20, 360-363.